Chromosome 7 and Haematological Malignancies

References

• Rowley J., Golomb, H. and Vardiman, J. (1981). Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood, 58(4), 759–767.
   PubMed Web of Science ®Google Scholar
• Yunis, J. J. (1984). Chromosomal defects are found in most patients with acute non-lymphocytic leukemia. Cancer Genetics and Cytogenetics, 11, 125–137.
   PubMed Web of Science ®Google Scholar
• Fagan, K., Gill, A., Henry, R., Wilkinson, I. and Carey, B. (1989). A summary of 7q interstitial deletions and exclusion mapping of the gene for beta-glucuronidase. Journal of Medical Genetics, 26, 619–625.
   PubMed Web of Science ®Google Scholar
• Fourth International Workshop on Chromosomes in Leukemia. Correlation of morphology and karyotype. Cancer Genetics and Cytogenetics, 1984, 11, 249–360.
   PubMed Web of Science ®Google Scholar
• Johansson, B., Mertens, F. and Mitelman, F. (1993). Cytogenetic Deletion Maps of Hematologic Neoplasms: Circumstantial Evidence for Tumour Suppressor Loci. Genes, Chromosomes and Cancer, 8, 205–218.
   PubMed Web of Science ®Google Scholar
• Van Wering, E., Kamps, W., Vossen, J., Van Der List-Nuver, C. and Theunissen, P. (1985). Myelodysplastic syndromes in childhood: three case reports. British Journal of Haematology, 60, 137–142.
   PubMed Web of Science ®Google Scholar
• Hogge, D., Shannon, K., Kalousek, D., Schonberg, S., Schaffner, V., Zoger, S., Eaves, C. and Eaves, A. (1987). Juvenile monosomy 7 syndrome: evidence that the disease originates in a pluripotent hemopoietic stem cell. Leukemia Research, 11, 705–709.
   PubMed Web of Science ®Google Scholar
• Michiels, J., Mallios-Zorbala, H., Prins, M. and Hahlen, K. (1986). Simple monosomy 7 and myelodysplastic syndrome in thirteen patients without previous cytostatic treatment. British Journal of Haematology, 64, 425–433.
   PubMed Web of Science ®Google Scholar
• Sieff, C., Chessells, J., Harvey, A., Pickthall, V. and Lawler, S. (1981). Monosomy 7 in childhood: a myeloproliferative disorder. British Journal of Haematology, 49, 235–249.
   PubMed Web of Science ®Google Scholar
• Creutzig, U., Cantu-Rajnoldi, A., Ritter, J., Romitti, L., Odenwald, E., Conter, V., Reihm, H. and Masera, G. (1987). Myelodysplastic syndromes in childhood. The American Journal of Pediatric Hematology/Oncology, 9(4), 324–330.
   PubMedGoogle Scholar
• Brandwein, J., Horsman, D., Eaves, A., Eaves, C., Massing, B., Wadsworth, L., Rogers, P. and Kalousek, D. (1990). Childhood myelodysplasia: suggested classification as myelodysplastic syndromes based on laboratory and clinical findings. The American Journal of Pediatric Hematology/Oncology, 12(1), 63–70.
   PubMedGoogle Scholar
• Hasle, H., Jacobsen, B. and Pedersen, N. (1992). Myelodysplastic syndromes in childhood: a population based study of nine cases. British Journal of Haematology, 81, 495–498.
   PubMed Web of Science ®Google Scholar
• Tuncer, M., Pagliuca, A., Hicsonmez, G., Yetgin, S., Ozsoylu, S. and Mufti, G. (1992). Primary myelodysplastic syndrome in children: the clinical experience in 33 cases. British Journal of Haematology, 82, 347–353.
   PubMed Web of Science ®Google Scholar
• Paietta, E., Gucalp, R. and Wiernik, P. (1991). Monosomy 7 in multilineage and acute lymphoblastic leukaemia. British Journal of Haematology, 79, 152–155.
   PubMed Web of Science ®Google Scholar
• Abrahamson, G., Boultwood, J., Madden, J., Kelly, S., Oscier, D., Rack, K., Buckle, V. and Wainscoat, J. (1991). Clonality of cell populations in refractory anaemia using combined approach, of gene loss and X-linked restriction fragment length polymorphism-methylation analyses. British Journal of Haematology, 79, 550–555.
   PubMed Web of Science ®Google Scholar
• Passmore, S. J., Hann, I. M., Stiller, C. A., Ramani, P., Swansbury, G. J., Gibbons, B., Reeves, B. R. and Chessells, J. M. (1995). Pediatric Myelodysplasia: A Study of 68 children and a New Prognostic Scoring System. Blood, 85(7), 1742–1750.
   PubMed Web of Science ®Google Scholar
• Weiss, K., Stass, S., Williams, D., Kalwinsky, D., Dahl, G., Wang, W., Johnson, F., Murphy, S. and Dow, L. (1987). Childhood monosomy 7 syndrome: clinical and in vitro studies. Leukemia, 1(2), 97–104.
   PubMed Web of Science ®Google Scholar
• Guinan, E., Tarbell, N., Tantravahi, R. and Weinstein, H. (1989). Bone marrow transplantation for children with myeloysplastic syndromes. British Journal of Haematology, 73(2), 619–622.
   Google Scholar
• Baranger, L., Baruchel, A., Leverger, G., Schaison, G. and Berger, R. (1990). Monosomy-7 in childhood hemopoietic disorders. Leukemia, 4(5), 345–349.
   PubMed Web of Science ®Google Scholar
• Daghistani, D., Toledano, S. and Curless, R. (1990). Monosomy 7 syndrome. Clinical heterogeneity in children and adolescents. Cancer Genetics and Cytogenetics, 44, 263–269.
   PubMedGoogle Scholar
• Mitelman, F., Nilsson, P.G., Brandt, L., Alimena, G., Gastaldi, R. and Dallapiccola, B. (1981). Chromosome pattern, occupation and clinical features in patients with acute non-lymphocytic leukemia. Cancer Genetics and Cytogenetics, 4, 197–214.
   PubMed Web of Science ®Google Scholar
• Rowley, J. D. (1980). Chromosome changes in acute leukaemia. British Journal of Haematology, 44, 339–346.
   PubMed Web of Science ®Google Scholar
• Le Beau, M., Albain, K., Larson, R., Vardiman, J., Davis, E., Blough, R., Golomb, H. and Rowley, J. (1986). Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no 5 and 7. Journal of Clinical Oncology, 4(3), 325–345.
   PubMed Web of Science ®Google Scholar
• Yunis, J. J., Rydell, R. E., Oken, M. M., Arnesen, M. A., Mayer, M. G. and Lobell, M. (1986). Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood, 67(6), 1721–1730.
   PubMed Web of Science ®Google Scholar
• Freireich, E. J., Whang, J., Tjio, J. H., Levin, R. H., Brittin, G. M. and Frei, E. (1964). Refractory anemia, granulocytic hyperplasia of bone marrow and a missing chromosome in marrow cells. A new clinical syndrome? Clin Res., 12, 284.
   Google Scholar
• Seizinger, B. R., Klinger, H. P., Junien, C., Nakamura, Y., Le Beau, M., Cavenee, W., Emanuel, B., Ponder, B., Naylor, S., Mitelman, F., Louis, D., Menon, A., Newsham, I., Decker, J., Kaelbling, M., Henry, I. V. and Diemling, A. (1991). Report of the committee on chromosome and gene loss in human neoplasia. Cytogen Cell Gen., 58, 1080–1096.
   Google Scholar
• Knudson, A. G. (1985). Hereditary cancer, oncogenes and antioncogenes. Cancer Research, 45, 1437–1443.
   PubMed Web of Science ®Google Scholar
• Kojima, S., Mimaya, J., Tonouchi, T., Yokochi, T. and Kajitani, S. (1987). Erythropoiesis during an erythroblastic phase of chronic myeloproliferative disorder associated with monosomy 7. British Journal of Haematology, 65, 391–394.
   PubMed Web of Science ®Google Scholar
• Greenberg, P., Cox, C., Le Beau, M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Osier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. and Bennett, J. (1997). International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 86(6), 2079–2088.
   Google Scholar
• Le Beau, M. M., Espinosa III, R., Neuman, W. L., Stock, W., Roulston, D., Larson, R. A., Keinanen, M. and Westbrook, C. A. Cytogenetic and molecular delineation of the smallest commonly deleted segment of chromosome 5 in malignant myeloid diseases. PNAS 1993.
   Google Scholar
• Gibbons, B., Lillington, D., Monard, S., Young, B., Cheung, K., Lister, A. and Kearney, L. (1994). Fluorescence in situ hybridisation studies to characterise complete and partial monosomy 7 in myeloid disorders. Genes, Chromosomes and Cancer, 10, 244–249.
   PubMed Web of Science ®Google Scholar
• Le Beau, M. M., Espinosa III, R., Davis, E. M., Eisenbart, J. D., Larson, R. A. and Green, E. D. (1996). Cytogenetic and molecular definition of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood, 88(6), 1930–1935.
   PubMed Web of Science ®Google Scholar
• Fischer, K., Frohling, S., Scherer, S. W., McAllister Brown, J., Scholl, C., Stilgenbauer, S., Tsui, L.-C., Lichter, P. and Dohner, H. (1997). Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood, 89(6), 2036–2014.
   PubMed Web of Science ®Google Scholar
• Luna-Fineman, S.S.K. and Lange, B. J. (1995). Childhood monosomy 7: Epidemiology, Biology, and Mechanistic Implications. Blood, 85(8), 1985–1999.
   PubMed Web of Science ®Google Scholar
• Wegelius, R. (1992). Bone marrow dysfunctions preceding acute leukemia in children: a clinical study. Leukemia Research, 16(1), 71–76.
   PubMed Web of Science ®Google Scholar
• Blank, J. and Lange, B. (1981). Preleukemia in children. The Journal of Pediatrics, 98(4), 565–568.
   PubMed Web of Science ®Google Scholar
• Nowell, P., Wilmoth, D. and Lange, B. (1983). Cytogenetics of childhood preleukemia. Cancer Genet. Cytogenet., 261–266.
   Google Scholar
• Mertens, F., Johansson, B. and Mitelman, F. (1993). Age- and gender-related heterogeneity of cancer chromosome abnormalities. Cancer Genetics and Cytogenetics, 70, 6–11.
   PubMed Web of Science ®Google Scholar
• Bennett, J., Catovsky, D., Daniel, M., Flandrin, G., Galton, D., Gralnick, H. and Sultan, C. (1982). group TF-A-BFc-o. Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189–199.
   PubMed Web of Science ®Google Scholar
• Jacobs, R. H., Cornbleet, M. A., Vardiman, J. W., Larson, R. A., Le Beau, M. M. and Rowley, J. D. (1986). Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood, 67, 1765–1772.
   PubMed Web of Science ®Google Scholar
• Kere, J., Ruutu, T., Davies, K., Roninson, I., Watkins, P., Winqvist, R. and De la Chapelle, A. (1989). Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping. Blood, 73(1), 230–234.
   PubMed Web of Science ®Google Scholar
• Kere, J., Donis-Keller, H., Ruutu, T. and De la Chapelle, A. (1989). Chromosome 7 long arm deletions in myeloid disorders: terminal DNA sequences are commonly conserved and breakpoints vary. Cytogenetics and Cell Genetics, 50, 226–229.
   PubMedGoogle Scholar
• Scheres, J. M. J. C., Hustink, T. W. J., Holdrinet, R. S. G., Geraedts, J. P. M., Hagemeijer, A. and van der Blij-Philipsen, M. (1984). Translocation 1:7 in dyshaematopoiesis: Possibly induced with a nonrandom geographic distribution. Cancer Genetics and Cytogenetics, 12, 283–294.
   PubMed Web of Science ®Google Scholar
• Scheres, J., Hustinx, T., Geraedts, J., Leeksma, C. and Meltzer, P. (1985). Translocation 1;7 in hematologic disorders: a brief review of 22 cases. Cancer Genetics and Cytogenetics, 18, 207–213.
   PubMed Web of Science ®Google Scholar
• Stefanescu, D., Colita, D., Nicoara, S. and Calin, G. (1994). t(1;7)(p36;q32): a new recurring abnormality in primary myelodysplastic syndrome. Cancer Genetics and Cytogenetics, 75, 103–105.
   PubMedGoogle Scholar
• Pedersen, B. (1992). Survival of patients with t(1;7)(p11;p11). Cancer Genetics and Cytogenetics, 60, 53–59.
   PubMed Web of Science ®Google Scholar
• Smadja, N., Krulik, M., de Gramont, A., Audebert, A. A. and Debray, J. (1985). Translocation 1;7 in preleukemic states. Cancer Genetics and Cytogenetics, 18, 189–192.
   PubMedGoogle Scholar
• Velloso, E. R. P., Michaux, L., Ferrant, A., Hernandez, J. M., Meeus, P., Dierlamm, J., Criel, A., Louwagie, A., Verhoef, G., Boogaerts, M., Michaux, J. -L., Bosly, A., Mecucci, C. and Van den Berghe, H. (1996). Deletions of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis. Brit. J. of Haem., 92, 574–581.
   PubMed Web of Science ®Google Scholar
• Yunis, J., Lobell, M., Arnesen, M., Oken, M., Mayer, M., Rydell, R. and Brunning, R. (1988). Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. British Journal of Haematology, 68, 189–194.
   PubMed Web of Science ®Google Scholar
• Parlier, V., Van Melle, G., Beris, P., Schmidt, P., Tobler, A., Haller, E. and Jotterand Bellomo, M. (1994). Hematologic, clinical and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Cancer Genetics and Cytogenetics, 78, 219–231.
   PubMed Web of Science ®Google Scholar
• Rowley, J. D. (1980). Chromosome abnormalities in acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics, 1, 263–271.
   Google Scholar
• Chan, L., Sheer, D., Drysdale, H., Bevan, D. and Greaves, M. (1985). Monosomy 7 and multipotential stem cell transformation. British Journal of Haematology, 61, 531–539.
   PubMed Web of Science ®Google Scholar
• Russo, C., Carroll, A., Kohler, S., Borowitz, M., Amylon, M., Homans, A., Kedar, A., Shuster, J., Land, V., Crist, W., Pullen, J. and Link, M. (1991). Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a pediatric oncology group study. Blood, 77(5), 1050–1056.
   PubMed Web of Science ®Google Scholar
• van Lom, K., Hagemeijer, A., Smit, E. M. E., Hahlen, K., Groeneveld, K. and Lowenberg, B. (1995). Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage. Leukemia, 9, 1818–1821.
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina, H., Shaison, G., Passe, S., Pasquier, A., Berger, R., Bayle-Weisgerber, C., Miller, D., Seligmann, M. and Bernard, J. (1984). Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Cancer, 54, 675.
   PubMed Web of Science ®Google Scholar
• Evans, J., Czepulkowski, B., Gibbons, B., Swansbury, G. and Chessells, J. (1988). Childhood monosomy 7 revisited. British Journal of Haematology, 69, 41–45.
   PubMed Web of Science ®Google Scholar
• Cuneo, A., Fagioli, F., Pazzi, I., Tallarico, A., Previati, R., Piva, N., Carli, M. G., Balboni, M. and Castoldi, G. (1992). Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents. Leuk Res., 16, 789.
   PubMed Web of Science ®Google Scholar
• Golomb, H. M., Alimena, G., Rowley, J. D., Vardiman, J. W., Testa, J. R. and Sovik, C. (1982). Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood, 60, 404–411.
   PubMed Web of Science ®Google Scholar
• Narod, S. and Dube, I. (1989). Occupational history and involvement of chromosomes 5 and 7 in acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics, 38, 261–269.
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard, J., Philip, P., Larsen, S., Jensen, G. and Byrsting, K. (1990). Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood, 76(6), 1083–1091.
   PubMed Web of Science ®Google Scholar
• Whang-Peng, J., Young, R., Lee, E., Longo, D., Schechter, G. and DeVita Jr, V. (1988). Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood, 71(2), 403–414.
   PubMed Web of Science ®Google Scholar
• Pui, C., Hancock, M., Raimondi, S., Head, D., Thompson, E., Wilimas, J., Kun, L., Bowman, L., Crist, W. and Pratt, C. (1990). Myeloid neoplasia in children treated for solid tumours. The Lancet, 336, 417–421.
   PubMed Web of Science ®Google Scholar
• Rubin, C., Arthur, D., Woods, W., Lange, B., Nowell, P., Rowley, J., Nachman, J., Bostrom, B., Baum, E., Suarez, C., Shah, N., Morgan, E., Maurer, H., McKenzie, S., Larson, R. and Le Beau, M. (1991). Therapyrelated myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood, 78(11), 2982–2988.
   PubMed Web of Science ®Google Scholar
• De Planque, M. M., Kluin-Nelemans, H. C., van Krieken, H. J. M., Kluin, P. M., Brand, A., Beverstock, G. C., Willemze, R. and van Rood, J. J. (1988). Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. British Journal of Haematology, 70, 55–62.
   PubMed Web of Science ®Google Scholar
• Imashuku, S., Hibi, S., Kataoka-Morimoto, Yoshihara, T., Ikushima, S., Morioka, Y. and Todo, S. (1995). Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration. British Journal of Haematology, 89, 188–190.
   PubMed Web of Science ®Google Scholar
• Kojima, S., Tsuchida, M. and Matsuyama, T. (1992). Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF. NEJM, 326, 1294.
   PubMed Web of Science ®Google Scholar
• Haber, D. A. and Housman, D. E. (1991). Rate-limiting steps: The genetics of pediatric cancers. Cell, 64, 5–8.
   PubMed Web of Science ®Google Scholar
• Kostmann, R. (1975). Infantile genetic agranulocytosis. Acta Paediatr Scand, 64, 362–368.
   PubMed Web of Science ®Google Scholar
• Bonilla, M. A., Gillio, A. P., Ruggeiro, M., Kernan, N. A., Brochstein, J. A., Abboud, M., Fumagalli, L., Vincent, M., Gabrilove, J. L., Welte, K., Souza, L. M. and O'Reilly, R. J. (1989). Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N. Engl. J. Med., 320, 1574–80.
   PubMed Web of Science ®Google Scholar
• Dale, D. C., Bonilla, M. A., Davis, M. W., Nakanishi, A. M., Hammond, W. P., Kurtzberg, J., Wang, W., Jakubowski, A., Winton, E., Lalezari, P., Robinson, W., Glaspy, J. A., Emerson, S., Gabrilove, J., Vincent, M. and Boxer, L. A. (1993). A randomized controlled phase 111 trial of recombinant human granulocyte colony-stimulating-factor (Filgrastim) for treatment of severe chronic neutropenia. Blood, 81, 2496–2502.
   PubMed Web of Science ®Google Scholar
• Dong, F., Brynes, R., Tidow, N., Welte, K., Lowenberg, B. and Touw, I. (1995). Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. NEJM, 333(8), 487–493.
   PubMed Web of Science ®Google Scholar
• Weinblatt, M. E., Scimeca, P., James-Herry, A., Sandev, I. and Kochen, J. (1995). Transformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child treated with granulocyte colony-stimulating factor. The J. of Pediatr., 126, 263–265.
   PubMed Web of Science ®Google Scholar
• Zeidler, C., Reiter, A., Schofer, O., Urban, C., Riehm, H. and Welte, K. (1992). Is severe congenital neutropenia (SCN) a pre-leukemic condition? Med. Pediatr. Oncol., 20, 445 (abstr).
   Google Scholar
• Wong, W., Williams, D. and Slovak MLea (1993). Terminal acute myelogenous leukemia in a patient with congenital agranulocytosis. Am. J. Hematol., 43, 133–8.
   PubMed Web of Science ®Google Scholar
• Shwachman, H., Diamond, L., Oski, F. and Khaw, K. (1964). The syndrome of pancreatic insufficiency and bone marrow dysfunction. The Journal of Pediatrics, 65(5), 645–663.
   PubMed Web of Science ®Google Scholar
• Woods, W., Roloff, J., Lukens, J. and Krivit, W. (1981). The occurrence of leukemia in patients with the Shwachman syndrome. J. Pediatr., 99, 425–428.
   PubMed Web of Science ®Google Scholar
• Seizinger, B. R. NF1: a prevalent cause of tumorigenesis in human cancers? Nature Genetics, 3, 97–99, Feb. 1993.
   PubMed Web of Science ®Google Scholar
• Bader, J. L. and Miller, R. W. (1978). Neurofibromatosis and childhood leukemia. The Journal of Pediatrics, 92, 925–929.
   PubMed Web of Science ®Google Scholar
• Stiller, C. A., Chessells, J. M. and Fitchett, M. (1994). Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br. J. Cancer, 76, 969–972.
   Web of Science ®Google Scholar
• Shannon, K. M., Watterson, J., Johnson, P., O'Connell, P., Lange, B., Shah, N., Steinherz, P., Kan, Y. W. and Priest, J. R. (1992). Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: Epidemiology and molecular analysis. Blood, 79(5), 1311–1318.
   PubMed Web of Science ®Google Scholar
• Shannon, K. M., O'Connell, P., Martin, G. A., Paderanga, D., Olson, K., Dinndorf, P. and McCormick, F. (1994). Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. NEJM, 330(9), 597–601.
   PubMed Web of Science ®Google Scholar
• Kaneko, Y. and Maseki, N. Sakurai Mea (1989). Chromosome pattern in juvenile chronic myeloid leukaemia, myelodysplastic syndrome and acute leukaemia associated with neurofibromatosis. Leukemia, 3, 36–41.
   PubMed Web of Science ®Google Scholar
• Side, L., Taylor, M., Cayouette, M., Conner, E., Thompson, P. and Shannon, K. (1997). Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N. Engl. J. Med., 336(24), 1713–1720.
   PubMed Web of Science ®Google Scholar
• Sherrington, P., Nacheva, E., Fischer, P., Rees, J., Hoyle, C., Dyer, M., Harper, P., Knight, C. and Hayhoe, G. (1988). Translocation 5;21 and interstitial deletion of chromosome 7 in a case of chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics, 31, 247–252.
   PubMed Web of Science ®Google Scholar
• Riccardi, V. M. and Eichner, J. E. (1986). Neurofibromatosis. Baltimore, MD, Johns Hopkins.
   Google Scholar
• Stephenson, J. and Lizhen, H. (1995). Possible coexistence of Ras activation and monosomy 7 in the leukaemic transformation of myelodysplastic syndromes. Leukemia Research, 19(10), 741–748.
   PubMed Web of Science ®Google Scholar
• Neubauer, A., Shannon, K. M. and Liu, E. (1991). Mutations of the ras proto-oncogenes in childhood monosomy 7. Blood, 77(3), 594–598.
   PubMed Web of Science ®Google Scholar
• Bollag, G., Clapp, D. W., Shih, S., Adler, F., Zhang, Y. Y., Thompson, P., Lange, B. J., Freedman, M. H., McCormick, F., Jacks, T. and Shannon, K. (1996). Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nature Genetics, 12, 144–148.
   PubMed Web of Science ®Google Scholar
• Fanconi, G. (1967). Familial constitutional panmyelocytopathy, Fanconi's anemia (FA). I. Clinical aspects. Semin Hematol., 4, 233–240.
   PubMedGoogle Scholar
• Auerbach, A. and Allen, R. (1991). Leukemia and preleukemia in Fanconi anemia patients. Cancer Genetics and Cytogenetics, 51, 1–12.
   PubMed Web of Science ®Google Scholar
• Berger, R., Le Coniat, M. and Schaison, G. (1993). Chromosome abnormalities in bone marrow of Fanconi anemia patients. Cancer Genetics and Cytogenetics, 65.
   PubMedGoogle Scholar
• Stivrins, T., Davis, R., Sanger, W., Fritz, J. and Purtilo, D. (1984). Transformation of Fanconi's anemia to acute nonlymphocytic leukemia associated with emergence of monosomy 7. Blood, 64(1), 173–176.
   PubMed Web of Science ®Google Scholar
• Hecht, F., Hecht, B., Morgan, R., Sandberg, A. and Link, M. (1986). Chromosome clues to acute leukemia in Down's syndrome. Cancer Genetics and Cytogenetics, 21, 93.
   PubMedGoogle Scholar
• Bunin, N., Nowell, P., Belasco, J., Shah, N., Willoughby, M., Farber, P. and Lange, B. (1991). Chromosome 7 abnormalities in children with Down syndrome and preleukemia. Cancer Genetics and Cytogenetics, 54, 119–126.
   PubMedGoogle Scholar
• Zipursky, A., Thorner, P., De Harven, E., Christensen, H. and Doyle, J. (1994). Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome. Leukemia Research, 18, 163–171.
   PubMed Web of Science ®Google Scholar
• Kaneko, Y., Rowley, J. D., Variakojis, D., Chilcote, R. R., Moohr, J. W. and Patel, D. (1981). Chromosome abnormalities in Down's syndrome patients with acute leukemia. Blood, 58, 459–466.
   PubMed Web of Science ®Google Scholar
• Carroll, W. L., Rodman Morgan, M. S. and Glader, B. E. (1985). Childhood bone marrow monosomy 7: A familial disorder? The J. of Peds., 107(4), 578–580.
   PubMed Web of Science ®Google Scholar
• Gilchrist, D., Friedman, J., Rogers, P. and Creighton, S. (1990). Myelodysplasia and leukemia syndrome with monosomy 7: A genetic perspective. American Journal of Medical Genetics, 35, 437–441.
   PubMed Web of Science ®Google Scholar
• Kamiyama, R., Shibata, T. and Mori, W. (1973). Two autopsy cases of atypical myeloproliferative disorder with group C monosomy occurring in siblings. Acta Pathol. Jpn, 23, 815.
   PubMedGoogle Scholar
• Larsen, W. E. and Schimke, R. W. (1976). Familial acute myelogenous leukemia with associated C-monosomy in two affected members. Cancer, 38, 841.
   PubMed Web of Science ®Google Scholar
• Li, F. P., Hecht, F., Kaiser-McCaw, B., Baranko, P. V. and Potter, N. U. (1981). Ataxia-pncytopenia syndrome of cerebellar ataxia, hypoplastic anemia, monosomy 7, and acute myelogenous leukemia. Cancer Genetics and Cytogenetics, 4, 189.
   PubMedGoogle Scholar
• Paul, B., Reid, M. M., Davison, E. V., Abela, M. and Hamilton, P. J. (1987). Familial myelodysplasia: progressive disease associated with emergence of monosomy 7. Brit. J. of Haem., 65, 321–323.
   PubMed Web of Science ®Google Scholar
• Chitambar, C. R., Robinson, W. A. and Glode, L. M. (1983). Familial leukemia and aplastic anemia associated with monosomy 7. Am. J. Med., 75, 756–762.
   PubMed Web of Science ®Google Scholar
• Shannon, K. M., Turhan, A. G., Chang, S. S. Y., Bowcock, A. M., Rogers, P. C. J., Carroll, W. L., Cowan, M. J., Glader, B. E., Eaves, C. J., Eaves, A. C. and Wai Kan, Y. (1989). Familial Bone Marrow Monosomy 7. J. Clin. Invest., 84, 984–989.
   PubMed Web of Science ®Google Scholar
• Shannon, K. M., Turhan, A. G., Rogers, P. C. J. and Kan, Y. W. (1992). Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukaemia associated with monosomy 7. Genomics, 14, 121–125.
   PubMed Web of Science ®Google Scholar
• Katz, F., Webb, D., Gibbons, B., Reeves, B., McMahon, C., Chessells, J. and Mitchell, C. (1992). Possible evidence for genomic imprinting in childhood acute myeloblastic leukaemia associated with monosomy for chromosome 7. British Journal of Haematology, 332–336.
   Google Scholar
• Savage, P., Frenck, R., Paderanga, D., Emporer, J. and Shannon, K. (1994). Parental origins of chromosome 7 loss in childhood monosomy 7. Leukemia, 8, 485.
   PubMed Web of Science ®Google Scholar
• Neuman, W., Rubin, C., Rios, R., Larson, R., Le Beau, M., Rowley, J., Vardiman, J., Schwartz, J. and Farber, R. (1992). Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomea 5 and 7 in malignant myeloid disorders. Blood, 79(6), 1501–1510.
   PubMed Web of Science ®Google Scholar
• Fischer, K., McAllister Brown, J., Scherer, S. W., Frohling, S., Scholl, C., Nickolenko, J., Stilgenbauer, S., Tsui, L.-C., Lichter, P. and Dohner, H. (1996). Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood, 88, suppl 1:65a.
   Google Scholar
• Kere, J. (1989). Chromosome 7 long arm deletion breakpoints in preleukemia: mapping by pulsed field gel electrophoresis. Nucleic Acids Research, 17(4), 1511–1520.
   PubMed Web of Science ®Google Scholar
• Kere, J., Ruutu, T., Lahtinen, R. and de la Chapelle, A. (1987). Molecular Characterisation of chromosome 7 long arm deletions in myeloid disorders. Blood, 70(5), 1349–1353.
   PubMed Web of Science ®Google Scholar
• Lewis, S., Abrahamson, G., Boultwood, J., Fidler, C., Potter, A. and Wainscoat, J. S. (1996). Molecular Characterization of the 7q deletion in myeloid disorders. British Journal of Haematology, 93, 75–80.
   PubMed Web of Science ®Google Scholar
• Butcher, M., Frenck, R., Emperor, J., Paderanga, D., Maybee, D. and Shannon, K. (1995). Molecular evidence that childhood monosomy 7 syndrome is distinct from juvenile chronic myelogenous leukemia and other childhood myeloproliferative disorders. Genes, Chromosomes and Cancer, 12, 50.
   PubMed Web of Science ®Google Scholar
• Abrahamson, G., Rack, K., Oscier, D., Fitchett, M., Buckle, V. and Wainscoat, J. (1993). Comparison of cytogenetic and restriction fragment length polymorphism analses for the detection of loss of chromosomal material in clonal hemopoietic disorders. American Journal of Hematology, 42, 171–176.
   PubMed Web of Science ®Google Scholar
• Zhao, L., Van Oort, J., Cork, A. and Liang, J. (1993). Comparison between interphase and metaphase cytogenetics in detecting chromosome 7 defects in hematological neoplasias. American Journal of Hematology, 43, 205–211.
   PubMed Web of Science ®Google Scholar
• Kibbelaar, R., Mulder, J., Dreef, E., Van Kamp, H. Fibbe, W., Wessels, J., Beverstock, G., Haak, H. and Kluin, P. (1993). Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. Blood, 82(3), 904–913.
   PubMed Web of Science ®Google Scholar
• Bentz, M., Dohner, H., Cabot, G. and Lichter, P. (1994). Fluorescence in situ hybridization in leukemias: ‘The FISH are spawning!’. Leukemia, 8, 1447–1452.
   PubMed Web of Science ®Google Scholar
• Kolluri, R. V., Manuelidis, L., Cremer, T., Sait, S., Gezer, S. and Raza, A. (1990). Detection of monosomy 7 in interphase cells of patients with myeloid disorders. American Journal of Haematology, 33, 117–122.
   PubMed Web of Science ®Google Scholar
• Johnson, E. J., Scherer, S. W., Osborne, L., Tsui, L. C., Oscier, D., Mould, S. and Cotter, F. C. (1996). Molecular definition of a narrow interval at 722.1 associated with myelodysplasia. Blood, 87, 3579–3586.
   PubMed Web of Science ®Google Scholar
• Stephenson, J., Czepulkowski, B., Hirst, W. and Mufti, G. J. (1996). Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). Leukemia Research, 20, 235–241.
   PubMed Web of Science ®Google Scholar
• Law, M. L., Cai, G.-Y., Lin, F.-K., Wei, Q., Huang, S.-Z., Hartz, J. H., Morse, H., Lin, C.-J., Jones, C. and Kao, F. T. (1986). Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism. PNAS, 83, 6920.
   PubMed Web of Science ®Google Scholar
• Kumar, S., White, D., Takai, S., Turczynowicz, S., Juttner, C. and Hughes, T. (1995). Apoptosis regulatory gene NEDD2 maps to human chromosome segment 7q34–35, a region frequently affected in haematological neoplasms. Human Genetics, 95, 641–644.
   PubMed Web of Science ®Google Scholar
• Kibbelaar, R., Mulder, J., Van Kamp, H., Dreef, E., Wessels, H., Beverstock, G., Haak, H., Raap, A. and Kluin, P. (1992). Nonradioactive in situ hybridisation of the translocation t(1; 7) in myeloid malignancies. Genes, Chromosomes and Cancer, 4, 128–134.
   PubMed Web of Science ®Google Scholar
• Gerritsen, W., Donohue, J., Bauman, J., Jhanwar, S., Kernan, N., Castro-Malaspina, H., O'Reilly, R. and Bourhis, J. (1992). Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood, 80(1), 217–224.
   PubMed Web of Science ®Google Scholar
• Baurman, H., Cherif, D. and Berger, R. (1993). Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7 associated myeloid disorders. Leukemia, 7(3), 384–391.
   PubMed Web of Science ®Google Scholar
• Johansson, B., Arheden, K., Hoglund, M., Othzen, A., Bekassy, A., Turesson, I., Heim, S. and Mitelman, F. (1995). Fluorescence in situ hybridization analysis of whole-arm 7; 12 translocations in hematologic malignancies. Genes, Chromosomes and Cancer, 14, 56–62.
   PubMed Web of Science ®Google Scholar
• Schrock, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M., Ning, Y., Ledbetter, D., Bar-Am, I., Soenksen, D., Garini, Y. and Ried, T. (1996). Multicolor spectral karyotyping of human chromosomes. Science, 273, 494–497.
   PubMed Web of Science ®Google Scholar
• Le Beau, M. M. (1996). One FISH, two FISH, red FISH, blue FISH. Nature Genetics, 12, 341–344.
   PubMed Web of Science ®Google Scholar
• Raza, A., Mundle, S., Iftikhar, A., Gregory, S., Marcus, B., Khan, Z., Alvi, S., Shetty, V., Dameron, S. and Wright, V. al. e. (1995). Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am. J. Hematol., 48(3), 143–154.
   PubMed Web of Science ®Google Scholar
• Rajapaksa, R., Ginzton, N., Rott, L. and Greenberg, P. (1996). Altered oncogene expression and apoptosis in myelodysplastic syndrome marrow cells. Blood, 88(11), 4275–4287.
   PubMed Web of Science ®Google Scholar
• Orazi, A., Kahsai, M., John, K. and Neiman, R. (1996). p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis. Mod. Pathol., 9(1), 48–52.
   PubMed Web of Science ®Google Scholar
• Mundle, S., Venugopal, P., Cartlidge, J., Pandav, D., Broady-Robinson, L., Gezer, S., Robin, E., Rifkin, S., Klein, M., Alston, D., Hernandez, B., Rosi, D., Alvi, S., Shetty, V., Gregory, S. and Raza, A. (1996). Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with meyelodysplastic syndrome. Blood, 88(7), 2640–2647.
   PubMed Web of Science ®Google Scholar
• DiGiuseppe, J., LeBeau, P., Augenbraun, J. and Borowitz, M. (1996). Multiparameter flow-cytometric analysis of bcl-2 and Fas expression in normal and neoplastic hematopoiesis. Am. J. Clin. Pathol., 106(3), 345–351.
   PubMed Web of Science ®Google Scholar
• Appelbaum, F. R., Storb, R., Ramberg, R. E., Shulman, H. M., Buckner, C. D., Clift, R. A., Deeg, H. J., Fefer, A., Sanders, J., Sullivan, K., Witherspoon, R. and Thomson, E. D. (1984). Allogeneic marrow transplantation in the treatment of preleukemia. Annals of Internal Medicine, 100, 689–693.
   PubMed Web of Science ®Google Scholar
• Borgstrom, G., Teerenhovi, L., Vuopio, P., De la Chapelle, A., Van Den Berghe, H., Brandt, L., Golomb, H., Louwagie, A., Mitelman, F., Rowley, J. and Sandberg, A. (1980). Clinical implications of monosomy 7 in acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics, 2, 115–126.
   Web of Science ®Google Scholar
• Sanders, J., Buckner, C., Thomas, E., Fleischer, R., Sullivan, K., Appelbaum, F. and Strob, R. (1988). Allogenic marrow transplantation for children with juvenile chronic myelogeneous leukemia. Blood, 74(4), 1144–1146.
   Google Scholar
• Appelbaum, F., Storb, R., Ramberg, R., Shulman, H., Buckner, C., Clift, R., Deeg, H., Fefer, A., Sanders, J., Self, S., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R. and Thomas, E. (1987). Treatment of preleukemic syndromes with marrow transplantation. Blood, 69, 92–96.
   PubMed Web of Science ®Google Scholar